Virtual Press Office and PR Newswire: General Trade show news https://stage.vporoom.com/tradeshownews/ CellGate to Showcase New Access Control Innovations at NAA Apartmentalize 2026 https://stage.vporoom.com/tradeshownews/2026-06-15-CellGate-to-Showcase-New-Access-Control-Innovations-at-NAA-Apartmentalize-2026 Mon, 15 Jun 2026 09:01:00 -0400 https://stage.vporoom.com/tradeshownews/2026-06-15-CellGate-to-Showcase-New-Access-Control-Innovations-at-NAA-Apartmentalize-2026 Process Industries Converge in Houston for Inaugural ChemE Show 2026 Powered by ACHEMA https://stage.vporoom.com/tradeshownews/2026-06-15-Process-Industries-Converge-in-Houston-for-Inaugural-ChemE-Show-2026-Powered-by-ACHEMA Mon, 15 Jun 2026 08:39:00 -0400 https://stage.vporoom.com/tradeshownews/2026-06-15-Process-Industries-Converge-in-Houston-for-Inaugural-ChemE-Show-2026-Powered-by-ACHEMA Neurocrine Biosciences Presents New Two-Year CRENESSITY® (crinecerfont) Data Demonstrating Improved Growth Measures in Pediatric Patients with Classic Congenital Adrenal Hyperplasia at ENDO 2026 https://stage.vporoom.com/tradeshownews/2026-06-15-Neurocrine-Biosciences-Presents-New-Two-Year-CRENESSITY-R-crinecerfont-Data-Demonstrating-Improved-Growth-Measures-in-Pediatric-Patients-with-Classic-Congenital-Adrenal-Hyperplasia-at-ENDO-2026 Mon, 15 Jun 2026 08:35:00 -0400 https://stage.vporoom.com/tradeshownews/2026-06-15-Neurocrine-Biosciences-Presents-New-Two-Year-CRENESSITY-R-crinecerfont-Data-Demonstrating-Improved-Growth-Measures-in-Pediatric-Patients-with-Classic-Congenital-Adrenal-Hyperplasia-at-ENDO-2026 365 Connect Unveils New Era of Multifamily Innovation with Autonomous Marketing and Leasing Platform at Apartmentalize in New Orleans https://stage.vporoom.com/tradeshownews/2026-06-15-365-Connect-Unveils-New-Era-of-Multifamily-Innovation-with-Autonomous-Marketing-and-Leasing-Platform-at-Apartmentalize-in-New-Orleans Mon, 15 Jun 2026 08:31:00 -0400 https://stage.vporoom.com/tradeshownews/2026-06-15-365-Connect-Unveils-New-Era-of-Multifamily-Innovation-with-Autonomous-Marketing-and-Leasing-Platform-at-Apartmentalize-in-New-Orleans Neurocrine Biosciences Presents New Two-Year CRENESSITY® (crinecerfont) Data Demonstrating Improvements in Cardiometabolic Outcomes in Adults with Classic Congenital Adrenal Hyperplasia at ENDO 2026 https://stage.vporoom.com/tradeshownews/2026-06-15-Neurocrine-Biosciences-Presents-New-Two-Year-CRENESSITY-R-crinecerfont-Data-Demonstrating-Improvements-in-Cardiometabolic-Outcomes-in-Adults-with-Classic-Congenital-Adrenal-Hyperplasia-at-ENDO-2026 Mon, 15 Jun 2026 08:30:00 -0400 https://stage.vporoom.com/tradeshownews/2026-06-15-Neurocrine-Biosciences-Presents-New-Two-Year-CRENESSITY-R-crinecerfont-Data-Demonstrating-Improvements-in-Cardiometabolic-Outcomes-in-Adults-with-Classic-Congenital-Adrenal-Hyperplasia-at-ENDO-2026